The R21 or Matrix-M vaccine has been developed by scientists at Oxford University & is the 2nd to receive WHO recommendation, after RTS,S or AS01 (brand name Mosquirix), approved in 2021.
GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.
Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.
After decades of failed attempts due to the complexity of the virus, two vaccines co-developed by US scientists being tested in large pilot schemes by Vietnamese companies, WHO said.
The data was a 'worrying warning signal' of rising vaccine hesitancy amid misinformation, dwindling trust in governments and political polarisation, UNICEF said.
Releasing Export Preparedness Index report, NITI Aayog CEO says Centre has ‘ticked a lot of boxes’, & responsibility of driving the next phase of export growth now rests with states.
The proposed project costing about Rs 3.25 lakh crore will entail procurement of 18 aircraft in fly away condition & the rest made in India with up to 60% indigenous content.
UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.
COMMENTS